A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
about
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipientsMycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipientsMycophenolate fetal toxicity and risk evaluation and mitigation strategiesLong-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis.Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy.Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.Mycophenolate mofetil--is it worth the cost? The in-favor opinion.Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.Current treatment practice in immunosuppression.Treatment of systemic lupus erythematosus with mycophenolate mofetil.Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings.Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.Molecular mechanisms of renal allograft fibrosis.Strategies to reduce toxicities and improve outcomes in renal transplant recipients.A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients.Cardiovascular toxicities of immunosuppressive agents.Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies.Mycophenolate mofetil monotherapy in the management of paediatric uveitis.Enteric-coated mycophenolate sodium.The use of mycophenolate mofetil in liver transplant recipients.Mycophenolate mofetil in solid-organ transplantation.Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.Review of the immunosuppressant enteric-coated mycophenolate sodium.Mycophenolate mofetil in patients with hepatitis C virus infection.Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.Individualization of mycophenolate mofetil dose in renal transplant recipients.Mycophenylate mofetil: what role in the treatment of lupus?Everolimus: an immunosuppressive agent in transplantation.Peripheral Lymphocyte Response to Mycophenolic Acid In Vitro and Incidence of Cytomegalovirus Infection in Renal TransplantationMycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability.Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry.Antifibrotic actions of mycophenolic acid.Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9.Calcineurin inhibitor-free immunosuppression in kidney transplantation.Unusual presentation of central nervous system manifestations of Varicella zoster virus vasculopathy in renal transplant recipients.Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysis.Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review.Pharmacogenetic influences on mycophenolate therapy.
P2860
Q24187213-8F50AE62-8424-4772-9874-85AE22247939Q24240797-DD9CCE02-8B89-4592-A654-DB3E8877EAB1Q26822840-23417908-3316-4656-B9A0-C990F5A80011Q30577281-FD33E470-1167-4729-A8D2-6F4A46090FF3Q30583015-4919004C-57CD-4B0E-8A68-1817DD6764B6Q31047067-6B979189-05EB-4B8B-A7E2-BA788C192B0AQ33408239-DFE24B9B-56DF-4609-B509-10144B7C2EACQ33652719-32A69A15-27A3-4AE5-BECF-B9C9E8FEAEC2Q33848529-8A3D2A63-C471-4320-871F-441C01AE49FBQ34006687-1837480B-BE36-42C6-959E-D4AB8606694BQ34181796-0890E0DF-BB00-4A7D-B515-77F9052DBDE4Q34227045-F1008BB0-7CF5-4145-AC5D-65E809654B74Q34363323-DDD01A9A-0831-4257-AAE9-0DE0676E706CQ34407897-2623A0D6-A11A-4DD9-A86E-3C8ABFDBE7EEQ34421501-A2AF1C29-6C45-47D1-B64F-48A4F0EFB93BQ34566924-B6D6AB82-E67B-4B15-B8DD-6A5F3C788CF8Q34805919-133A763B-91AE-4D07-AB2F-4B28FF02E5C8Q34976738-61326426-3104-4CE1-BD54-2F9A263C48EDQ34993934-387A6835-5188-41A2-9BB7-DECF9FA09D8AQ35208743-B5433533-FB3A-4E34-9D47-83DA6D4961FEQ35562618-6BF16A09-CBEA-452B-BC4A-5D1A30B4662CQ35574966-8621E6CF-6F03-4143-B55C-D2E02C499483Q35594016-777672E3-FE49-426D-BA53-C5CB45F0EC48Q35708692-2ED825DA-18BD-4161-B643-24BD0416206FQ35784063-B72D4065-73EB-47FC-A8EC-B6B8B8F5F0EAQ36085885-E1BA1D44-5E97-4EC1-82C7-788B6643A302Q36371451-78B19AFA-9BED-479B-BE32-513CD70CEB70Q36407345-972144DB-5B18-4400-91C8-3B922C005C30Q36458168-E9FC7E1E-6CCE-4B92-88CD-C1C30A42053AQ36521866-92170BD8-5842-48E5-9B92-30837E77C5C7Q36528717-96D0F575-F89E-4428-A5CB-95AA3607402BQ36544988-D22CAC71-C935-4BB7-8F3C-36E748D57204Q36566866-05757552-382C-43B6-A12A-DE214BF07DBCQ36652027-3D8BCC48-E8DB-4177-8E47-36F666748F9CQ36792638-BDF42212-86A5-4CB2-829A-FC09BED01402Q36889001-25464F24-195E-409D-A58A-0ADC0C7A324EQ36907601-2DA99A27-2BE1-425E-A1C0-1BDAB3E268D4Q37280007-08F1027C-8C6A-408A-8377-0B1C22312327Q37581617-F35A2D81-493C-4028-BF68-3ABC2CAF17E3Q37710509-94C68F78-E4C1-492F-A911-BF4A55362F60
P2860
A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
description
im April 1996 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 1996
@uk
name
A BLINDED, RANDOMIZED CLINICAL ...... DAVERIC RENAL TRANSPLANTATION1
@en
A BLINDED, RANDOMIZED CLINICAL ...... DAVERIC RENAL TRANSPLANTATION1
@nl
type
label
A BLINDED, RANDOMIZED CLINICAL ...... DAVERIC RENAL TRANSPLANTATION1
@en
A BLINDED, RANDOMIZED CLINICAL ...... DAVERIC RENAL TRANSPLANTATION1
@nl
prefLabel
A BLINDED, RANDOMIZED CLINICAL ...... DAVERIC RENAL TRANSPLANTATION1
@en
A BLINDED, RANDOMIZED CLINICAL ...... DAVERIC RENAL TRANSPLANTATION1
@nl
P1433
P1476
A BLINDED, RANDOMIZED CLINICAL ...... DAVERIC RENAL TRANSPLANTATION1
@en
P304
P356
10.1097/00007890-199604150-00008
P577
1996-04-01T00:00:00Z